A pooled analysis of 3 large multicenter trials confirms a survival advantage for NPM1mut AML in MRDneg remission after intensive induction

Research output: Contribution to journal › Letter › Contributed › peer-review

Contributors

  • Konstanze Döhner - , Ulm University Medical Center (Author)
  • Hartmut Döhner - , Ulm University Medical Center (Author)
  • Daniela Späth - , Ulm University Medical Center (Author)
  • Silke Kapp-Schwoerer - , Ulm University Medical Center (Author)
  • Amanda Gilkes - , Cardiff University (Author)
  • Ian Thomas - , Cardiff University (Author)
  • Sean Johnson - , Cardiff University (Author)
  • Nicola Potter - , King's College London (KCL) (Author)
  • Yana Bevan - , King's College London (KCL) (Author)
  • Jad Othman - , King's College London (KCL) (Author)
  • Nigel H Russell - , Nottingham University Hospitals NHS Trust (Author)
  • Christoph Röllig - , Department of Internal Medicine I (Author)
  • Christian Thiede - , Department of Internal Medicine I (Author)
  • Martin Bornhäuser - , Department of Internal Medicine I (Author)
  • Thomas Oellerich - , Goethe University Frankfurt a.M. (Author)
  • Tressa Hood - , Kronos Bio, Inc. (Author)
  • Jenna Elder - , PharPoint Research, Inc. (Author)
  • Luis A Carvajal - , Kronos Bio, Inc. (Author)
  • Jorge DiMartino - , Kronos Bio, Inc. (Author)
  • Richard Dillon - , King's College London (KCL) (Author)

Details

Original languageEnglish
Article numbere70198
JournalHemaSphere
Volume9
Issue number8
Publication statusPublished - Aug 2025
Peer-reviewedYes

External IDs

PubMedCentral PMC12371262
Scopus 105013824476

Keywords